A 73-year-old woman developed bilateral panuveitis after receiving Dostarlimab for endometrial cancer, presenting with reduced vision and inflammation in both eyes.
* The patient had a history of immune-related issues that led to the discontinuation of Dostarlimab, and she subsequently experienced other complications like pneumonitis and pancreatitis.
* Treatment with corticosteroids improved her symptoms, but this case highlights a potential ocular side effect of Dostarlimab, which has not been documented before.
Introduction: This study was designed to examine the capacity of intraoperative optical coherence tomography (OCT) to predict the postimplant position of the glaucoma drainage device PreserfloTM.